Heart and brain -: The influence of psychiatric disorders and their therapy on the heart rate variability

被引:33
作者
Birkhofer, A
Schmidt, G
Förstl, H
机构
[1] Tech Univ Munich, Klin & Poliklin Psychiat & Psychotherap, D-81675 Munich, Germany
[2] Tech Univ Munich, Med Klin & Poliklin, Munich, Germany
关键词
D O I
10.1055/s-2004-830109
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Psychiatric disorders are associated with autonomic dysregulations. There is evidence that these dysregulations are partly responsible for the increased mortality in patients with psychiatric disorders. The determination of the heart rate variability (HRV) is a method easily applicable and allows the assessment of the autonomic control of the heart rate regulation. A multitude of HRV parameters with different physiological meanings have been introduced, the most widely used parameters are presented and characterized in this paper. Many studies have shown a reduced HRV in patients with major depression. Most studies found a reduced parasympathetic activity. However some authors discuss an elevated sympathetic activity. The magnitude of HRV reduction correlates to the severity of the depression. In patients with coronary diseases, major depression is an independent risk factor of mortality. Antidepressive therapy with serotonine reuptake inhibitors has failed to improve the prognosis of this patients. Patients with panic disorders also have a reduced HRV due to an elevated sympathetic control and reduced vagal control. In schizophrenic patients a reduced HRV was found in long term electrocardiogram recordings, whereas short term recordings did not show a reduced HRV. Patients with Alzheimer's disease also have a reduced HRV, which is limited to the low frequency component. Therapy with cholinesterase inhibitors further influences HRV by reducing the high frequency component and might increase the risk for arrhythmias. HRV analysis and integration in the assessment and monitoring of psychiatric patients before and during therapy elucidate the role of autonomic disturbances in such diseases and may help to optimize treatment.
引用
收藏
页码:192 / 205
页数:20
相关论文
共 188 条
[1]   Comorbidity between cardiovascular disease and affective illness [J].
Agelink, MW ;
Baumann, B ;
Sanner, D ;
Kavuk, I ;
Mueck-Weymann, M .
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2004, 129 (13) :697-700
[2]   Does acupuncture influence the cardiac autonomic nervous system in patients with minor depression or anxiety disorders? [J].
Agelink, MW ;
Sanner, D ;
Eich, H ;
Pach, J ;
Bertling, R ;
Lemmer, W ;
Klieser, E ;
Lehmann, E .
FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 2003, 71 (03) :141-149
[3]   Relationship between major depression and heart rate variability. Clinical consequences and implications for antidepressive treatment [J].
Agelink, MW ;
Boz, C ;
Ullrich, H ;
Andrich, J .
PSYCHIATRY RESEARCH, 2002, 113 (1-2) :139-149
[4]   Effects of reboxetine, a selective norepinephrine reuptake inhibitor, on sympathetic and parasympathetic outflow to the heart: preliminary data [J].
Agelink, MW ;
Ullrich, H ;
Baumann, B ;
Strum, S ;
Majewski, T .
PSYCHOPHARMACOLOGY, 2002, 163 (02) :151-156
[5]   Effects of newer atypical antipsychotics on autonomic neurocardiac function: A comparison between amisulpride, olanzapine, sertindole, and clozapine [J].
Agelink, MW ;
Majewski, T ;
Wurthmann, C ;
Lukas, K ;
Ullrich, H ;
Linka, T ;
Klieser, E .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2001, 21 (01) :8-13
[6]   Autonomic neurocardiac function in patients with major depression and effects of antidepressive treatment with nefazodone [J].
Agelink, MW ;
Majewski, T ;
Wurthmann, C ;
Postert, T ;
Linka, T ;
Rotterdam, S ;
Klieser, E .
JOURNAL OF AFFECTIVE DISORDERS, 2001, 62 (03) :187-198
[7]   Cardiovascular autonomic reactivity in schizophrenics under neuroleptic treatment: A potential predictor of short-term outcome? [J].
Agelink, MW ;
Malessa, R ;
Kamcili, E ;
Zeit, T ;
Lemmer, W ;
Bertling, R ;
Klieser, E .
NEUROPSYCHOBIOLOGY, 1998, 38 (01) :19-24
[8]   INCREASED SYMPATHETIC AND DECREASED PARASYMPATHETIC CARDIAC INNERVATION IN PATIENTS WITH ALZHEIMERS-DISEASE [J].
AHARONPERETZ, J ;
HAREL, T ;
REVACH, M ;
BENHAIM, SA .
ARCHIVES OF NEUROLOGY, 1992, 49 (09) :919-922
[9]  
ALGOTSSON A, 1995, ACTA NEUROL SCAND, V91, P14
[10]   DEPRESSED AFFECT, HOPELESSNESS, AND THE RISK OF ISCHEMIC-HEART-DISEASE IN A COHORT OF UNITED-STATES ADULTS [J].
ANDA, R ;
WILLIAMSON, D ;
JONES, D ;
MACERA, C ;
EAKER, E ;
GLASSMAN, A ;
MARKS, J .
EPIDEMIOLOGY, 1993, 4 (04) :285-293